FibroBiologics, Inc. Common Stock (FBLG) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.36M | -3.16M | -3.97M | -3.98M | -5.28M | -3.07M | -2.61M | -1.95M | -4.28M | -1.6M | -1.14M | -1.63M | -2.04M | -1.17M | -763 |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 17.27% | -2.93% | -52.42% | -104.62% | -23.39% | -91.94% | -128.8% | -19.82% | -109.97% | -36.49% | - | - | -266741.42% | - | - |
| Net Income | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.02K |
| Depreciation & Amortization | 237K | 234K | 231K | 206K | 161K | 153K | 143K | 140K | 137K | 130K | 112K | 99K | 96K | 229K | 59 |
| Stock-Based Compensation | 694K | 702K | 704K | 729K | 551K | 544K | 571K | 578K | 525K | 432K | 437K | 448K | 448K | 32K | 84 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -54K | 481K | 813K | 218K | 534K | -392K | -2.78M | -4.03M | 3.1M | 7.24M | 0 | 60K | 93K | 265K | 93 |
| Working Capital Changes | -241K | -1.34M | 58K | -479K | -1.55M | -279K | -44K | 463K | 419K | 318K | 504K | -71K | -258K | -175K | 19 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -275K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -95K | 0 | 0 | 384K | -1.03M | 1.52M | -29K | 394K | -630K | 275K | 222K | -23K | 197K | 0 | 0 |
| Cash from Investing | 0 | 0 | -6K | -213K | -43K | -99K | -11K | -66K | -8K | -2K | -413K | -24K | -56K | 0 | 0 |
| Capital Expenditures | 0 | 0 | -6K | -213K | -43K | -99K | -11K | -66K | -8K | -2K | -413K | -24K | -56K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 952K | 3.19M | 0 | 4.38M | 0 | 9.33M | 4.47M | -172K | 3.28M | 0 | 940K | -1.71M | 14.57M | 2.15M | 2.04K |
| Debt Issued (Net) | 246K | -3.4M | 0 | 4.38M | 0 | 9.29M | -172K | -172K | 459K | 0 | 0 | 300K | 0 | 0 | 0 |
| Equity Issued (Net) | 706K | 6.59M | 0 | 0 | 0 | 45K | 4.64M | 0 | 2.82M | 0 | 940K | 10.31M | 4.89M | 2.15M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.32M | 9.68M | 0 | 2.04K |
| Net Change in Cash | -3.41M | 27K | -3.98M | 178K | -5.32M | 6.16M | 1.85M | -2.19M | -1M | -1.6M | -612K | -3.36M | 12.47M | 977K | 0 |
| Free Cash Flow | -4.36M | -3.16M | -3.98M | -4.2M | -5.32M | -3.17M | -2.62M | -2.01M | -4.28M | -1.6M | -1.55M | -1.65M | -2.09M | -1.17M | -763 |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 17.94% | 0.28% | -52.01% | -108.49% | -24.17% | -97.88% | -68.62% | -22.07% | -104.73% | -36.66% | - | - | -274080.86% | - | - |
| FCF per Share | -1.95 | -1.42 | -1.85 | -2.17 | -2.90 | -1.82 | -1.56 | -1.23 | -2.75 | -1.01 | -0.96 | -1.02 | -1.29 | -0.77 | -0.00 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.98x | 0.69x | 0.86x | 1.06x | 0.99x | 5.21x | -2.17x | 0.51x | 0.16x | 0.52x | 0.75x | 0.84x | 0.77x | 0.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 6K | 0 | 0 | 4K | 1K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |